Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22281125 | 0.84 | CA12 (0.43) | TSHRTDP1 | |
| SCHEMBL21553357 | 0.84 | TSHR (0.48) | TSHR | |
| SCHEMBL19101281 | 0.81 | TP53 (0.41) | TSHRTDP1 | |
| SCHEMBL20244146 | 0.78 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL20900682 | 0.77 | TSHR (0.30) | TSHRTDP1 | |
| SCHEMBL22273251 | 0.77 | — | — | |
| SCHEMBL5933402 | 0.75 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL27292689 | 0.75 | — | — | |
| SCHEMBL23945391 | 0.73 | KDM4E (0.40) | — | |
| SCHEMBL18532233 | 0.73 | ADH1B (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230031576-A1 | RADIOLABELLED TARGETING LIGANDS | Clarity Pharmaceuticals Ltd (AU) | 2023-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230031576-A1 | RADIOLABELLED TARGETING LIGANDS | FOLH1, CXCR3, ACKR3 | TSHR 191/4885TDP1 2603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.